Vaxart has adjourned its 2025 special meeting of stockholders to September 19, 2025, providing additional time for stockholders to vote due to changes in Board composition and governance considerations.
The reverse stock split proposal was deferred to allow stockholders more time for deliberation in light of recent changes and potential disclosures.
The reconvened Special Meeting will be held virtually, and Vaxart is actively soliciting votes from stockholders on all proposals set forth in the Proxy Statement.
Meeting Adjourned
The Special Meeting of Stockholders has been rescheduled to September 19, 2025, to accommodate changes in Board composition and allow additional time for voting.
Virtual Format
The reconvened Special Meeting will be conducted in a virtual-only format for ease of access for stockholders, emphasizing digital engagement.
Encouraging Participation
Vaxart urges stockholders who have not yet voted to do so before September 18, 2025, emphasizing the importance of shareholder engagement and decision-making.
- The adjournment of the Special Meeting suggests a proactive approach by Vaxart to ensure thorough consideration of proposals, reflecting a commitment to transparency and shareholder inclusivity.
- The decision to defer the reverse stock split proposal indicates a responsive stance to feedback and the evolving corporate landscape, fostering a climate of open dialogue with stakeholders.
Vaxart's adjournment of the Special Meeting highlights the company's dedication to governance and shareholder democracy, underlining its commitment to transparent communication and informed decision-making.